What is the significance of the phenomenon of hypertension in disguise in patients with type 2 diabetes mellitus treated for long-lasting hypertension?

Česká verzia

Authors: Jiří Charvát
Authors place of work: Interní klinika 2. LF UK a FN Motol, Praha
Published in the journal: Vnitř Lék 2016; 62(3): 215-217
Category: Reviews

Summary

“Hypertension in disguise” is quite frequent in the patients with diabetes mellitus. It leads to organ damage similarly as persistent hypertension and it is associated with an increased cardiovascular risk which can be reduced through effective treatment. Persistent hypertension is present in 70% of the patients with type 2 diabetes mellitus. During its treatment, the picture of “masked hypertension” may be imitated (normalized blood pressure taken at a day clinic, as opposed to the increased values outside of it). This finding occurs in 35–60 % of the patients with type 2 diabetes mellitus and it is associated with the significance of changes to internal organs. The importance of this finding has been under discussion.

Key words:
type 2 diabetes mellitus – cardiovascular risk – masked hypertension

Zdroje

1. Sowers JR. Treatment of hypertension in patients with diabetes. Arch Intern Med 2004; 164(17): 1850–1857.

2. Cífková R. Léčba hypertenze u pacientů s diabetem. Farmakoterapie 2008; 4(3): 303–308.

3. Souček M. Hypertenze u pacienta s diabetes mellitus. Vnitř Lék 2010; 56(9 Suppl): 995–999.

4. Pickering TG, Davidson K, Gerin W et al. Masked hypertension. Hypertension 2002; 40(6): 795–796.

5. Bobrie G, Clerson P, Menard J et al. Masked hypertension: a systematic review. J Hypertension 2008; 26(9): 1715–1725.

6. Chobanian AV, Bakris GL, Black H et al. The seventh Report of the Joint National Comittee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 Report. JAMA 2003; 289(19): 2560–2572.

7. Ohkubo T, Imai Y, Tsuji I et al. Home blood measurement has stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohasama. J Hypertension 1998; 16(7): 971–975.

8. Palatini P, Winnicki M, Snatonastaso M et al. Prevalence and clinical significance of isolated ambulatory hypertension in young subjects screened for stage 1 hypertension. Hypertension 2004; 44(2): 170–174.

9. Hanninem MR, Niiranen TJ, Puukka PJ et al. Determinants of masked hypertension in the general population: the Finn-Home study. J Hypertension 2011; 29(10): 1880–1888.

10. Franklin SS, Thijs L, Li Y et al. Masked hypertension in diabetes mellitus. Treatment Implications and Clinical Practice. Hypertension 2013; 61(5): 964–971.

11. Uzu T, Nakao K, Kume S et al. High Sodium Intake is associated with masked hypertension in Japanese patients with Type 2 Diabetes and Treated Hypertension. Am J Hyperten 2012; 25(11): 1170–1174.

12. Charvát J, Chlumský J, Szabo M et al. The association of masked hypertension in treated type 2 diabetes patients with carotid artery IMT. Diab Res Clin Pract 2010; 89(3): 239–242.

13. Leiria LF, Severo MD, Ledur PS et al. White coat effect and masked uncontrolled hypertension in treated hypertensive-diabetic patients. Prevalence and target organ damage. J Diabetes 2015; 7(5): 699–707.

14. Cushman WC, Evans GW, Byington RP et al. Effects of intensive blood-pressure control in Type 2 Diabetes Mellitus. N Engl J Med 2010; 362(17): 1575–1585.

15. Cooper-De Hoff RM, Gong Y, Handberg EM et al. Tight Blood Pressure Control and Cardiovascular Outcome Among Hypertensive Patients with Diabetes and Coronary Artery Disease. JAMA 2010; 304(1): 61–68.

16. UKPDS SG: Tight blood pressure control and risk of macrovascular and microvascular complications in Type 2 diabetes: UKPDS 38: UK Prospective Diabetes Study Group. BMJ 1998; 317(7160): 703–713.